Clinical Trial Update: PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for PF-00299804 in stage IIIB/IV non-small cell lung cancer previously treated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PF-00299804

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-10-27